Editas Medicine (EDIT) Reports Q4 Loss of $1.00/sh

Editas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($1.00), versus ($0.74) reported last year. Revenue for the quarter came in at $11.4 million, versus $12.3 million reported last year.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
• The LGL Group (LGL) Misses Q2 EPS by 8c